Name: UMIN ID:
Unique ID issued by UMIN | UMIN000005388 |
---|---|
Receipt number | R000006397 |
Scientific Title | Randomized Phase II trial of Neoadjuvant weekly Nab-paclitaxel followed by FEC compared with Docetaxel followed by FEC for early breast cancer |
Date of disclosure of the study information | 2011/06/01 |
Last modified on | 2021/04/27 15:22:28 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2011/04/06 15:54:33 | ||
2 | Update | 2011/07/19 14:02:59 | Acronym |
|
3 | Update | 2011/07/20 09:55:48 | Acronym |
|
4 | Update | 2012/04/09 17:07:17 | Post marketing survey by drug manufacture etc., specified by Japanese law. Institutions |
|
5 | Update | 2012/11/12 15:57:58 | Organization2 Address2 Tel2 Email2 |
|
6 | Update | 2013/04/11 13:13:35 | Last name of contact person Last name of contact person Institutions |
|
7 | Update | 2014/04/07 16:40:33 | Email Institutions |
|
8 | Update | 2014/04/07 16:43:09 | Recruitment status |
|
9 | Update | 2016/04/08 10:37:28 | Name of primary person or sponsor Organization Tel2 |
|
10 | Update | 2020/04/16 11:45:17 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Organization Organization Division name Division name Zip code TEL Last name of contact person Last name of contact person Organization Organization Division name Division name Zip code TEL Organization Organization Division name Division name Name of primary person or sponsor Institute Institute Department Organization2 Organization Organization Address Address Tel |
|
11 | Update | 2021/04/27 15:22:29 | TEL Last name of contact person Last name of contact person TEL Email2 |